$156 Million is the total value of Newman Dignan & Sheerar, Inc.'s 135 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DEO | Exit | Diageo Plc | $0 | – | -1,794 | -100.0% | -0.15% | – |
| BHP | Exit | BHP Billiton Ltd Adradr | $0 | – | -5,180 | -100.0% | -0.15% | – |
| AMLP | Exit | Alerian MLP ETFetf | $0 | – | -13,696 | -100.0% | -0.15% | – |
| CMI | Exit | Cummins Inc | $0 | – | -1,660 | -100.0% | -0.16% | – |
| A309PS | Exit | DIRECTV | $0 | – | -2,476 | -100.0% | -0.17% | – |
| HCN | Exit | Health Care Reit Inc | $0 | – | -3,500 | -100.0% | -0.17% | – |
| ABBV | Exit | AbbVie Inc | $0 | – | -3,447 | -100.0% | -0.17% | – |
| RAD | Exit | Rite Aid Corp | $0 | – | -29,100 | -100.0% | -0.18% | – |
| APC | Exit | Anadarko Petroleum | $0 | – | -3,108 | -100.0% | -0.18% | – |
| Exit | Air Prods & Chems | $0 | – | -1,800 | -100.0% | -0.18% | – | |
| REGN | Exit | Regeneron Pharm | $0 | – | -526 | -100.0% | -0.19% | – |
| NXPI | Exit | Nxp Semiconductors Nv | $0 | – | -2,920 | -100.0% | -0.21% | – |
| SNI | Exit | Scripps Networks Interactiveetf | $0 | – | -4,665 | -100.0% | -0.22% | – |
| QCOM | Exit | Qualcomm Corp | $0 | – | -5,382 | -100.0% | -0.24% | – |
| UTHR | Exit | United Therapeutics Corp | $0 | – | -1,969 | -100.0% | -0.25% | – |
| SYNA | Exit | Synaptics Inc | $0 | – | -3,965 | -100.0% | -0.25% | – |
| WDC | Exit | Western Digital Corp | $0 | – | -4,526 | -100.0% | -0.26% | – |
| HPQ | Exit | Hewlett Packard | $0 | – | -14,617 | -100.0% | -0.32% | – |
| EBAY | Exit | Ebay Inc | $0 | – | -7,633 | -100.0% | -0.33% | – |
| L | Exit | Lowes Companies | $0 | – | -7,762 | -100.0% | -0.37% | – |
| VWO | Exit | Vanguard Emerging Mkt Fdetf | $0 | – | -15,264 | -100.0% | -0.45% | – |
| TAPA | Exit | Molson Coors Brewing | $0 | – | -11,145 | -100.0% | -0.56% | – |
| VTV | Exit | Vanguard Valueetf | $0 | – | -17,882 | -100.0% | -1.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-10-23
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Schwab Dow Jones US Div Eq ETF | 42 | Q3 2023 | 6.6% |
| Schwab Dow Jones US Large Cap ETF | 42 | Q3 2023 | 7.3% |
| Schwab Dow Jones US Large Growth ETF | 42 | Q3 2023 | 4.9% |
| Schwab Dow Jones US Large Value ETF | 42 | Q3 2023 | 4.5% |
| Apple, Inc | 42 | Q3 2023 | 20.8% |
| Schwab Dow Jones US Sm-Cap ETF | 42 | Q3 2023 | 13.5% |
| Microsoft Corp | 42 | Q3 2023 | 3.4% |
| Johnson & Johnson | 42 | Q3 2023 | 2.9% |
| Novartis A G | 42 | Q3 2023 | 56.8% |
| Merck & Co Inc | 42 | Q3 2023 | 2.5% |
View Newman Dignan & Sheerar, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-02 |
| 13F-HR | 2023-04-28 |
| 13F-HR | 2023-01-20 |
| 13F-HR | 2022-10-18 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-04-14 |
| 13F-HR | 2022-01-18 |
View Newman Dignan & Sheerar, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.